Newsletter | April 11, 2026
FOCUS ON OUTSOURCING
February 2026 — CDMO Opportunities And Threats Report
GlobalData
Pioneering Affordable CAR-T Cell Therapies In India
By Dr. Phalguni Deswal, Vector BioMed
New Standards For Elastomeric Components In Sterile Packaging
By Christian Collazo-Sarra, Pace Life Sciences
Lentiviral Vectors: The Key To Cell And Gene Therapy Success
SK pharmteco
The 14 Month Race: How Partnership And Capability Developed A Gene Therapy
Andelyn Biosciences
CRISPR Gene Editing, CDMOs, And The Art Of "Just Right"
Aldevron
Consistency You Can Trust In Animal‑Free Raw Materials
Nu-Tek Biosciences
FOCUS ON MANUFACTURING
Rethinking ATMP Assurance When Sterility Timelines, Reality Misalign
A conversation with Jose Caraballo-Oramas
Cell And Gene Therapy CDMOs: On The Path To $75 Billion In Services?
By Louis Garguilo, chief editor, Outsourced Pharma
Advanced Technology Platform For Stem Cell-Derived Exosomes
By Elie Zakhem, Jae Jung, Cameron Garland, et al., Repligen
Rethink Capital Efficiency In Cell Processing
CARR Biosystems
How To Identify Optimal Materials For Biopharma Single-Use Solutions
Charter Medical
Revolutionizing Cell Therapy Manufacturing With AI
Invetech
UF Devices Offer Higher-Throughput Options For Cloning And PCR Workflows
Cytiva
Why Your Bioanalysis Bottleneck Is Costing You More Than You Think
Dash Bio
Optimizing rAAV Production Using An In-House Suspension HEK293 Cell Line
By Chris Brown, Yeonji Kim, Jing Zhu, and Xiaojun Liu, Recipharm Advanced Bio
Next-Generation Cell Therapy: Eliminating Thermal Shock In Electroporation
Femtobiomed Inc.
The New Economics Of Cell Therapy Manufacturing
Connection Technologies Enable Modular Single-Use Systems
By Todd Andrews, CPC
Cutting AAV Production Costs Through Enzymatic DNA Methods
Touchlight
Navigating The Journey From Preclinical Research To Clinical Trials
Lonza
Outsourcing For Beginners: Cell & Gene Therapy Modalities
AGC Biologics
Enhancing Plasmid DNA Yield And ITR Stability In E. Coli Platforms
By Shrey Amin, Ssempa Kisaalita, Sneha Vilayur, et al., ProBio
Redefining The Analytical Frameworks Surrounding Capsid Characterization
By Achille François, Viralgen
Scaling Productivity Through Perfusion And Upstream Intensification
Thermo Fisher Scientific
Path To IND: AAV Transient Transfection And Producer Cell Line Platforms
Scalable Plasmid-Free Platforms For Commercial AAV Production
Minaris
Formulation: The Key To Long‑Term Success
By Michaela Breitsamer, Coriolis Pharma
FOCUS ON REGULATORY & COMPLIANCE
Ensuring Quality Of CGT Materials
By Erin Harris, chief editor, Cell & Gene
Clearing The Path To Approval: Residual Reagent Control In AAV Gene Therapy
Mirus Bio
Optimizing Syringe Performance For Reliable Drug Delivery
West Pharmaceutical Services, Inc.
The Role Of GMP Excipients In Cell Culture Development
Nucleus Biologics
Navigating New FDA Guidance On Written IRB Policies
Univo IRB
The Importance Of Tube Welding In Aseptic Bioprocessing
Ensorcell
A Risk-Based Decision Framework For Selecting Aseptic Barrier Technologies
By Sastia Susanti, Esco Lifesciences
Smart Manufacturing: A Strategic Imperative For Pharma's Future
Siemens
A Comparative Analysis Between Liquid Nitrogen And Mechanical Freezers
PHC Corporation of North America
Your Environmental Monitoring Can't Be Your Only Line Of Defense
Contec, Inc.
Real-Time Clinical Data Insights Delivered By Automation And AI
Revvity Signals Software, Inc.
Essential Quality Standards For GMP Raw Materials
ACROBiosystems
The Power Of Collaboration In Uncertain Times
By Deborah Kobewka, BioPhorum
FOCUS ON SUPPLY CHAIN
Ever Wonder What Running A $50B Capital Facilities Project Feels Like?
A conversation with Victor Cruz, Eli Lilly & Company
Optimizing Packaging Systems For Reliable Drug Substance Transport
By Joe Cintavey, W.L. Gore & Associates
A Practical Guide To Choosing The Right Cold Storage Solutions
FOCUS ON CLINICAL TRIALS
Assess The Success Of CRISPR Gene Therapies Using ddPCR Technology
By Marwan Alsarraj, Bio-Rad Laboratories, Inc.
Tailoring An Approach To Support Bladder Cancer Breakthrough
Worldwide Oncology
Slow The Burn: How To Make Risk-Resilient Vendor Choices
By Raul P. Lima, InSeption Group
21% Of CGT Clinical Holds Stem From CMC Issues. What Does This Tell Us?
Solvias
How Intelligent Automation Transforms Vendor Selection
By Matt Failor, ClinAI
Inside The Payer Perspective On Cell And Gene Therapy Coverage
Cencora
How The Cell And Gene Therapy Market Is Taking Shape
Terumo BCT
